Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data
View ORCID ProfileStefano De Leo
doi: https://doi.org/10.1101/2021.09.27.21264130
Stefano De Leo
Department of Applied Mathematics, Campinas State University, Brazil
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data are available in the Tables of the paper.
Posted September 28, 2021.
Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data
Stefano De Leo
medRxiv 2021.09.27.21264130; doi: https://doi.org/10.1101/2021.09.27.21264130
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (657)
- Anesthesia (176)
- Cardiovascular Medicine (2557)
- Dermatology (216)
- Emergency Medicine (388)
- Epidemiology (12055)
- Forensic Medicine (10)
- Gastroenterology (738)
- Genetic and Genomic Medicine (3970)
- Geriatric Medicine (373)
- Health Economics (663)
- Health Informatics (2561)
- Health Policy (991)
- Hematology (356)
- HIV/AIDS (821)
- Medical Education (393)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3732)
- Nursing (206)
- Nutrition (558)
- Oncology (1940)
- Ophthalmology (565)
- Orthopedics (233)
- Otolaryngology (299)
- Pain Medicine (246)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1087)
- Primary Care Research (442)
- Public and Global Health (6401)
- Radiology and Imaging (1352)
- Respiratory Medicine (854)
- Rheumatology (390)
- Sports Medicine (336)
- Surgery (430)
- Toxicology (51)
- Transplantation (184)
- Urology (161)